Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | $0.26 | N/A | N/A | -0.07x | -0.11x | 0.97x | -0.11x | N/A | -$19.58M | -822.69% | -$32.16M | -3.51 | $12.17M | -0.52 | ||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $6.35 | N/A | N/A | -0.72x | -16.17x | N/A | -6.63x | N/A | -$7.68M | -94.91% | -$1.56M | -1.22 | $10.24M | -0.92 | ||
| XAIR | BEYOND AIR INC | $3.09 | N/A | N/A | -0.05x | -0.47x | 0.29x | 1.48x | N/A | -$19.60M | -879.32% | $2.00M | 2.77 | $15.64M | -0.62 | ||
| LGVN | LONGEVERON INC | $2.49 | N/A | N/A | -0.25x | -0.34x | 6.59x | 0.76x | N/A | -$20.53M | -262.81% | $10.40M | 3.32 | -$779.39k | 0.03 | ||
| VVOS | VIVOS THERAPEUTICS INC | $0.16 | N/A | N/A | -0.09x | -0.12x | 0.14x | -0.86x | N/A | -$19.01M | -659.51% | -$3.82M | -0.22 | $14.01M | -0.59 | ||
| CNTX | CONTEXT THERAPEUTICS INC | $0.37 | N/A | N/A | -0.77x | -0.78x | N/A | 0.89x | N/A | -$34.03M | -97.01% | $38.17M | 0.40 | -$8.93M | 0.20 | ||
| DVLT | DATAVAULT AI INC | $0.15 | N/A | N/A | -15.00x | -1.63x | 2.34x | 0.58x | N/A | -$92.21M | -84.67% | $245.89M | 0.34 | $146.28M | -0.93 | ||
| GOVX | GEOVAX LABS INC | $0.36 | N/A | N/A | -0.04x | -0.02x | N/A | 1.49x | N/A | -$18.37M | -1,127.17% | $1.76M | 0.39 | -$189.46k | 0.01 | ||
| ITRG | INTEGRA RESOURCES CORP | $2.79 | N/A | N/A | 69.75x | N/A | 2.19x | 2.08x | N/A | $5.55M | 0.97% | $271.41M | 1.34 | $484.91M | 8.51 | ||
| IVVD | INVIVYD INC | $0.76 | N/A | N/A | -2.29x | -1.41x | 4.15x | 1.23x | N/A | -$109.66M | -45.30% | $181.08M | 0.57 | $70.85M | -0.67 | ||
| EVTL | VERTICAL AEROSPACE LTD | $0.63 | N/A | N/A | -6.73x | -0.64x | N/A | -1.89x | N/A | -$190.16M | -217.06% | -$46.40M | -0.34 | $150.21M | 13.52 | ||
| TENX | TENAX THERAPEUTICS INC | $1.90 | N/A | N/A | -1.28x | -1.28x | N/A | 0.63x | N/A | -$46.03M | -47.63% | $113.59M | 2.23 | -$46.87M | 0.72 | ||
| GUTS | FRACTYL HEALTH INC | $0.60 | N/A | N/A | -0.68x | -1.72x | N/A | -57.36x | N/A | -$82.44M | -86.67% | -$1.67M | -0.01 | $109.10M | -1.06 | ||
| ELTX | ELICIO THERAPEUTICS INC | $1.89 | N/A | N/A | -0.87x | -0.94x | N/A | 6.26x | N/A | -$37.71M | -103.65% | $7.94M | 0.41 | $40.34M | -1.15 | ||
| ACTU | ACTUATE THERAPEUTICS INC | $0.98 | N/A | N/A | -1.13x | -1.05x | N/A | 23.82x | N/A | -$19.84M | -84.71% | $989.15k | 0.04 | $19.13M | -0.94 | ||
| KSCP | KNIGHTSCOPE INC | $1.14 | N/A | N/A | -0.33x | -0.42x | 0.99x | 0.91x | N/A | -$44.63M | -218.42% | $29.60M | 1.65 | $26.71M | -0.64 | ||
| ANVS | ANNOVIS BIO INC | $1.14 | N/A | N/A | -0.64x | -0.63x | N/A | -11.42x | N/A | -$43.34M | -101.32% | -$4.25M | -0.11 | $29.84M | -0.60 | ||
| NRXP | NRX PHARMACEUTICALS INC | $3.32 | N/A | N/A | -6.04x | 7.82x | 36.89x | -845.54x | N/A | -$20.67M | -16.54% | -$170.00k | -0.01 | $118.30M | -5.41 | ||
| VERU | VERU INC | $2.41 | N/A | N/A | -4.16x | -2.33x | N/A | 1.45x | N/A | -$26.04M | -46.89% | $28.38M | 1.23 | $19.89M | -1.47 | ||
| CRVO | CERVOMED INC | $2.43 | N/A | N/A | -0.75x | -0.89x | 75.94x | 1.60x | N/A | -$27.98M | -112.39% | $22.96M | 2.24 | $14.28M | -0.47 | ||
| NMRA | NEUMORA THERAPEUTICS INC | $0.73 | N/A | N/A | -0.59x | -0.82x | N/A | 3.08x | N/A | -$180.32M | -133.42% | $44.52M | 0.24 | $73.58M | -0.36 | ||
| GRI | GRI BIO INC | $1.93 | N/A | N/A | -0.13x | -0.40x | N/A | 0.41x | N/A | -$10.42M | -298.96% | $10.28M | 5.70 | -$6.68M | 0.69 | ||
| BEAT | HEARTBEAM INC | $0.40 | N/A | N/A | -0.79x | -1.05x | N/A | 2.78x | N/A | -$14.01M | -65.76% | $8.18M | 0.16 | $13.99M | -0.69 | ||
| ATOS | ATOSSA THERAPEUTICS INC | $2.22 | N/A | N/A | -0.50x | -0.55x | N/A | 0.83x | N/A | -$35.78M | -180.95% | $26.83M | 3.01 | -$4.05M | 0.11 | ||
| HUMA | HUMACYTE INC | $0.59 | N/A | N/A | -1.15x | -1.45x | 65.11x | 5.21x | N/A | -$97.56M | -71.16% | $31.26M | 0.13 | $148.86M | -1.88 | ||
| OCGN | OCUGEN INC | $1.06 | N/A | N/A | -4.08x | -4.24x | 75.71x | -21.71x | N/A | -$61.02M | -16.98% | -$16.56M | -0.05 | $347.07M | -4.93 | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $0.86 | N/A | N/A | -5.75x | -4.45x | 33.15x | 3.06x | N/A | -$20.34M | -12.65% | $39.23M | 0.21 | $118.84M | -4.51 | ||
| OTLK | OUTLOOK THERAPEUTICS INC | $0.65 | N/A | N/A | -0.85x | -1.30x | -72.56x | -15.30x | N/A | -$56.15M | -62.94% | -$10.39M | -0.08 | $166.16M | -2.67 | ||
| INTZ | INTRUSION INC | $0.61 | N/A | N/A | -1.11x | -1.59x | 2.15x | 5.36x | N/A | -$10.71M | -86.07% | $2.79M | 0.14 | $19.56M | -2.11 | ||
| LESL | LESLIE's INC | $0.42 | N/A | N/A | -0.02x | -0.10x | 0.00x | -0.01x | N/A | -$6.35M | -163.37% | -$492.74M | -52.63 | $979.43M | -5.98 | ||
| CMPX | COMPASS THERAPEUTICS INC | $1.90 | N/A | N/A | -4.87x | -3.72x | N/A | 2.06x | N/A | -$56.38M | -15.89% | $166.05M | 0.89 | $315.78M | -4.39 | ||
| TARA | PROTARA THERAPEUTICS INC | $3.55 | N/A | N/A | -2.61x | -2.42x | N/A | 1.30x | N/A | -$66.49M | -30.70% | $161.31M | 2.64 | $195.46M | -2.81 | ||
| SION | SIONNA THERAPEUTICS INC | $5.96 | N/A | N/A | -2.75x | -2.40x | N/A | 1.01x | N/A | -$76.21M | -28.32% | $265.78M | 5.89 | $213.25M | -2.25 | ||
| OSTX | OS THERAPIES INC | $1.77 | N/A | N/A | -1.62x | -2.41x | N/A | -6.85x | N/A | -$18.53M | -23.84% | -$11.91M | -0.27 | $81.44M | -2.10 | ||
| RNTX | REIN THERAPEUTICS INC | $0.80 | N/A | N/A | -0.47x | -1.78x | N/A | 1.25x | N/A | -$18.83M | -35.13% | $55.20M | 0.82 | $60.47M | -1.20 | ||
| ENHA | ENHANCED GROUP INC | $1.44 | N/A | N/A | -0.46x | -1.82x | 9.60x | 182.43x | N/A | -$76.18M | -44.93% | $3.06M | 0.03 | $538.84M | -6.21 | ||
| EYPT | EYEPOINT INC | $3.85 | N/A | N/A | -1.03x | -1.01x | 120.31x | 1.99x | N/A | -$271.12M | -81.38% | $166.41M | 1.92 | $241.12M | -0.79 | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $0.92 | N/A | N/A | -1.35x | -1.06x | 53.88x | 6.26x | N/A | -$61.65M | -48.47% | $18.22M | 0.13 | $86.14M | -1.18 | ||
| ADGM | ADAGIO MEDICAL HOLDINGS INC | $0.48 | N/A | N/A | -0.35x | -0.43x | N/A | -25.80x | N/A | -$16.57M | -154.77% | -$415.00k | -0.02 | $28.97M | -1.25 | ||
| CLNN | CLENE INC | $4.35 | N/A | N/A | -1.24x | -2.21x | 271.88x | -2.26x | N/A | -$15.95M | -29.61% | -$24.78M | -2.00 | $68.51M | -1.98 | ||
| ALGS | ALIGOS THERAPEUTICS INC | $5.24 | N/A | N/A | -0.71x | -0.76x | 1.73x | 2.05x | N/A | -$94.52M | -172.94% | $31.88M | 3.06 | $38.52M | -0.53 | ||
| CRBU | CARIBOU BIOSCIENCES INC | $1.30 | N/A | N/A | -1.20x | -1.24x | 21.31x | 1.42x | N/A | -$95.75M | -72.92% | $98.10M | 0.97 | $139.83M | -1.40 | ||
| CABA | CABALETTA BIO INC | $2.55 | N/A | N/A | -1.68x | -1.89x | N/A | 2.05x | N/A | -$154.21M | -40.00% | $210.59M | 1.39 | $232.95M | -1.46 | ||
| NGEN | NERVGEN PHARMA CORP | $2.05 | N/A | N/A | -3.71x | N/A | N/A | 17.59x | N/A | N/A | N/A | $12.40M | 0.13 | $155.84M | N/A | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $1.03 | N/A | N/A | -7.36x | -14.43x | 19.81x | 4.28x | N/A | -$24.39M | -9.51% | $60.92M | 0.24 | $225.44M | -6.13 | ||
| MRLN | MERLIN INC | $1.95 | N/A | N/A | -0.02x | -0.64x | 16.53x | -1.97x | N/A | -$114.37M | -64.26% | -$99.93M | -1.09 | $13.05M | -0.06 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.